Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin

Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin

Doxorubicin (Dox) is the most widely used chemotherapeutic agent and is considered a highly powerful and broad-spectrum for cancer treatment. However, its application is compromised by the cumulative side effect of dose-dependent cardiotoxicity. Because of this, targeted drug delivery systems (DDS)...

Full description

Bibliographic Details
Main Authors: Nayelli Guadalupe Teran-Saavedra, Jose Andrei Sarabia-Sainz, Enrique Fernando Velázquez-Contreras, Gabriela Ramos-Clamont Montfort, Martín Pedroza-Montero, Luz Vazquez-Moreno
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Molecules
Subjects:
doxorubicin
drug delivery systems
hepatocellular carcinoma
asialoglycoprotein receptor
lactosylated albumin
core-shell nanoparticles
Online Access:https://www.mdpi.com/1420-3049/25/22/5432

Internet

https://www.mdpi.com/1420-3049/25/22/5432

Similar Items